Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The PDRN HA Skincare Serum is a topical cosmetic product developed by Aowita Biotech, combining polydeoxyribonucleotide (PDRN) and hyaluronic acid (HA). PDRN is a DNA-derived ingredient, typically extracted from salmon sperm, that acts as an agonist at adenosine A2A receptors to promote tissue repair, reduce inflammation, and stimulate collagen synthesis. Hyaluronic acid is a high-molecular-weight polysaccharide that functions as a humectant, binding water to the skin to enhance hydration and maintain barrier integrity. This combination is specifically formulated for cosmetic applications, targeting skin brightening and the reduction of hyperpigmented spots by improving overall skin health and cellular regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polydeoxyribonucleotide + hyaluronic acid.